Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Alterations in plasma triglycerides lipolysis in patients with history of multifactorial chylomicronemia.

Atherosclerosis - 1 Oct 2017

Marmontel Oriane, Di Filippo Mathilde, Marcais Christophe, Nony Séverine, Dumoux Marjorie, Serveaux-Dancer Marine, Caussy Cyrielle, Charrière Sybil, Moulin Philippe

Abstract excerpt

BACKGROUND AND AIMS: The heterogeneity and mechanisms of multifactorial chylomicronemia (MCM) remain poorly understood. To gain new insights, post heparin lipolysis measured at 60 min (PHLA60), in addition to the more commonly used 10 min (PHLA10), was assessed in patients with history of MCM. METHODS: 62 consecutive MCM patients were studied. The evaluation included LPL, APOC2, APOA5, GPIHBP1, LMF1 and APOE gene...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Case-Control Studies

Share to Genetic Predisposition to Disease

Share to Hyperlipoproteinemia Type I

Share to Lipolysis

Share to Multifactorial Inheritance

Share to Triglycerides

Source

Identifiers

PMID: 28829998
DOI: 10.1016/j.atherosclerosis.2017.07.030

Genes

LPL
APOE
LMF1
APOA5
APOC2
GPIHBP1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Alterations in plasma triglycerides lipolysis in patients with history of multifactorial chylomicronemia.PMID 28829998Read ↗

Contemporary Management of Familial and Multifactorial Chylomicronemia Syndromes in Italy: Insights From the National LIPIGEN Registry.Semantic proximity Read ↗

Clinical identification of familial chylomicronemia syndrome and novel therapeutic options.Semantic proximity Read ↗

Multifactorial chylomicronemia: keys to detecting severe forms.Semantic proximity Read ↗

The GPIHBP1-LPL complex and its role in plasma triglyceride metabolism: Insights into chylomicronemia.Semantic proximity Read ↗

Genetic and biochemical analysis of severe hypertriglyceridemia complicated with acute pancreatitis or with low post-heparin lipoprotein lipase mass.Semantic proximity Read ↗

Comprehensive analysis of Chinese patients with non-LPL familial chylomicronemia syndrome: Genetic variants, dietary interventions, and clinical insights.Semantic proximity Read ↗

Chylomicronemia: Differences between familial chylomicronemia syndrome and multifactorial chylomicronemiaSemantic proximity Read ↗

Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an "FCS score".Semantic proximity Read ↗

Analyses of Familial Chylomicronemia Syndrome And Multifactorial Chylomicronemia In Colombia 2010-2020: A Cross-Sectional StudySemantic proximity Read ↗

10-Year Comparative Follow-up of Familial versus Multifactorial Chylomicronemia Syndromes.Semantic proximity Read ↗

Clinical and biochemical features of different molecular etiologies of familial chylomicronemiaSemantic proximity Read ↗

Rare Variants in Triglycerides-Related Genes Increase Pancreatitis Risk in Multifactorial Chylomicronemia Syndrome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.